FDA expands approval of Zelboraf (vemurafenib) to include treatment of certain adult patients with Erdheim-Chester Disease, a rare blood cancer. This is the first FDA-approved treatment for ECD.
from Food and Drug Administration--Press Releases http://ift.tt/2hgxQn9
via IFTTT
No comments:
Post a Comment